跳至主要内容
临床试验/NL-OMON38311
NL-OMON38311已完成不适用

BeSt for kids: A randomized clinical trial to test the effectiveniss of different treatment strategies in patients with Juvenile Idiopathic Arthritis - BeSt for kids: comparing treatment strategies in JIA

Academisch Medisch Centrum0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • all new patients with oligoarticular JIA (persistent and extended), RF negative polyarticular JIA and juvenile psoriatic arthritis according to ILAR classification
  • diagnosis between age 2-16 years
  • treated in one of the Dutch pediatric rheumatology centers
  • with a maximum of 18 months symptoms
  • patients with polyarthritis with active disease requiring a DMARD
  • patients with oligoarthritis requiring a DMARD (i.e.with active disease despite 4 months NSAIDs and/or intra-articular glucocorticoids

排除标准

  • systemic JIA, RF positive JIA, JIA with enthesitis, unclassified JIA
  • previous treatment with DMARDs or biologicals
  • known contraindication for one of the study drugs
  • bone marrow hypoplasia
  • a compromised immune system
  • sepsis or risk of sepsis
  • See page 14 of the protocol

研究者

相似试验